Novozymes Establishing New Innovation Campus in Denmark


North Carolina’s Novozymes has signed a deal with Lyngby-Taarbæk Municipality to acquire a 140,000 square meter site in Lyngby, Denmark. The site is located 13 kilometers north of Copenhagen and seven kilometers from its European headquarters in Bagsværd.

Novozymes’ goal is to build a new campus dedicated to research and business development.

“This is an investment in the future, where the new innovation campus will be a cornerstone for our global research. Novozymes is driven by innovation and this center will help strengthen our growth through developing ground-breaking biotechnology,” says Per Falholt, executive vice president for R&D at Novozymes.

More information is available here:


Leave a Reply

Your email address will not be published. Required fields are marked *